Calcitonin Gene-Related Peptide Systemic Effects: Embracing the Complexity of Its Biological Roles—A Narrative Review

A Bonura, N Brunelli, M Marcosano… - International Journal of …, 2023 - mdpi.com
The calcitonin gene-related peptide (CGRP) is a neuropeptide widely distributed throughout
the human body. While primarily recognized as a nociceptive mediator, CGRP antagonists …

Artificial intelligence modeling of biomarker‐based physiological age: Impact on phase 1 drug‐metabolizing enzyme phenotypes

AG Bhat, M Ramanathan - CPT: Pharmacometrics & Systems …, 2024 - Wiley Online Library
Age and aging are important predictors of health status, disease progression, drug kinetics,
and effects. The purpose was to develop ensemble learning‐based physiological age (PA) …

Generative models for age, race/ethnicity, and disease state dependence of physiological determinants of drug dosing

R Nair, DD Mohan, S Setlur, V Govindaraju… - … of Pharmacokinetics and …, 2023 - Springer
Dosing requires consideration of diverse patient-specific factors affecting drug
pharmacokinetics and pharmacodynamics. The available pharmacometric methods have …

Bayesian network model of ethno-racial disparities in cardiometabolic-based chronic disease using NHANES 1999–2018

MA Babagoli, MJ Beller, JP Gonzalez-Rivas… - Frontiers in Public …, 2024 - frontiersin.org
Background Ethno-racial disparities in cardiometabolic diseases are driven by
socioeconomic, behavioral, and environmental factors. Bayesian networks offer an …

Non‐neurological factors associated with serum neurofilament levels in the United States population

M Ramanathan - Annals of Clinical and Translational …, 2024 - Wiley Online Library
Objective To model interdependencies of serum neurofilament light chain (sNfL), a clinically
useful biomarker of axonal injury in neurological diseases, with demographic …

Generation of realistic virtual adult populations using a model-based copula approach

Y Guo, T Guo, CAJ Knibbe, LB Zwep… - … of Pharmacokinetics and …, 2024 - Springer
Incorporating realistic sets of patient-associated covariates, ie, virtual populations, in
pharmacometric simulation workflows is essential to obtain realistic model predictions …

Building virtual patients using simulation-based inference

N Paul, V Karamitsou, C Giegerich… - Frontiers in Systems …, 2024 - frontiersin.org
In the context of in silico clinical trials, mechanistic computer models for pathophysiology
and pharmacology (here Quantitative Systems Pharmacology models, QSP) can greatly …

Computational design of clinical trials using a combination of simulation and the genetic algorithm

S Tsuchiwata, Y Tsuji - CPT: Pharmacometrics & Systems …, 2023 - Wiley Online Library
Artificial intelligence (AI) has come to be used in various technological fields in recent years.
However, there have been no reports of AI‐designed clinical trials. In this study, we tried to …

Editor's note on the themed issue: integration of machine learning and quantitative systems pharmacology

PL Bonate - Journal of Pharmacokinetics and Pharmacodynamics, 2022 - Springer
In a few short years, quantitative systems pharmacology (QSP) has become a major tool
available to pharmacometricians to improve decision making in drug development, so much …

Machine learning and financial big data control using IoT

J Xiao - Intelligent Decision Technologies - content.iospress.com
Abstract Machine learning algorithms have been widely used in risk prediction management
systems for financial data. Early warning and control of financial risks are important areas of …